Palihapitiya-backed SPAC to take ProKidney public in over $2 bln deal

Prokidney

18/01/2022 12:05

Jan 18 (Reuters) - Biotech company ProKidney LP is going
public through a merger with a blank-check firm backed by
veteran dealmaker Chamath Palihapitiya, in a deal that values
the combined company at $2.64 billion, the companies said on
Tuesday.
    

 (Reporting by Niket Nishant and Sohini Podder in Bengaluru;
Editing by Aditya Soni)
 ((Niket.Nishant@thomsonreuters.com;))